Core Viewpoint - The company, Yantai Ruichuang Micro-Nano Technology Co., Ltd., is positioned in a promising industry with significant growth potential in the infrared thermal imaging market, driven by increasing demand and technological advancements [1][2][3] Industry Development Outlook - The infrared thermal imaging industry is characterized as a sunrise industry with low penetration rates, indicating substantial future growth opportunities [1][2] - The demand for civilian infrared products is expected to maintain rapid growth due to decreasing prices and increasing applications [1][2] Company Position and Financial Health - Ruichuang Micro-Nano holds a strong market position in the non-cooling infrared thermal imaging segment, being one of the few companies capable of independent research and mass production of non-cooling infrared detector chips [1][2][3] - The company has a robust cash position and diverse sales channels, which provide a solid foundation for debt repayment [1][2] Revenue and Profitability - The company reported total revenue of 43.16 billion yuan in 2024, reflecting a year-on-year growth of 21.28% [7][8] - The adjusted gross margin for 2024 was 45.21%, indicating an increase from previous years, driven by the growth in the infrared thermal imaging business [8] R&D and Innovation - The company has a well-established R&D framework, with R&D expenses amounting to 8.61 billion yuan in 2024, representing 19.94% of total revenue [13][15] - The company has achieved significant technological advancements, including the development of the world's first large-area non-cooling infrared detector with a pixel pitch of 8μm [13][15] Market Risks and Challenges - The company faces ongoing pressures from rapid technological updates and intense market competition, necessitating continuous innovation and R&D investment [2][3] - The concentration of accounts receivable and inventory remains high, which poses potential asset impairment risks [2][3] Investment Projects and Use of Proceeds - The proceeds from the convertible bond issuance are primarily allocated to various projects, including the supply chain center for infrared thermal imaging systems, which is expected to be completed on schedule [3][4] - As of March 2025, the company has utilized 11.54 billion yuan of the 20 billion yuan planned for investment projects, with significant progress reported in the supply chain center project [3][4]

评级机构上海新世纪在对公司经营状况及相关行业进行综合分析与评估的基 础上，于 2025 年 6 月 10 日出具了《2022 年烟台睿创微纳技术股份有限公司向不 特定对象发行可转换公司债券定期跟踪评级报告》(新世纪跟踪（2025）100057 ), 前次债券评级: 公司主体信用等级为"AA"，"睿创转债"的信用等级为"AA"， 并将睿创微纳及睿创转债列入评级观察名单。 本次债券评级: 公司主体信用等级为"AA"，移出评级观察名单，评级展 望为"稳定"，"睿创转债"的信用等级为"AA"。 | 证券代码：688002 | 证券简称：睿创微纳 | 公告编号：2025-041 | | --- | --- | --- | | 转债代码：118030 | 转债简称：睿创转债 | | 烟台睿创微纳技术股份有限公司 关于"睿创转债"跟踪信用评级结果的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 根据《上市公司证券发行注册管理办法》《上海证券交易所科创板股票上市 规则》等有关规定，烟台睿创微纳技术股份有限公司(以下简 ...

内部编号:2025060042 2022 年烟台睿创微纳技术股份有限公司 向不特定对象发行可转换公司债券 定期跟踪评级报告 项目负责人: 王婷亚 黄梦姣 足榜在 书,男女 wty@shxsj.com hmj@shxsj.com 项目组成员: 张明海 82-167 评级总监: 联系电话:(021)63501349 联系地址:上海市黄浦区汉口路 398 号华盛大厦 14 层 公司网站：www.shxsj.com 上海新世纪资信评估投资服务有限公司 Shanghai Brilliance Credit Rating & Investors Service Co., Ltd. t a serie 声明 除因本次评级事项使本评级机构与评级对象构成委托关系外,本评级机构、评级人员与评级对象不存在任何影响 评级行为独立、客观、公正的关联关系。 本评级机构与评级人员履行了调查和诚信义务，所出具的评级报告遵循了真实、客观、公正的原则。 本报告版权归本评级机构所有，未经授权不得修改、复制、转载、散发、出售或以任何方式外传。 未经本评级机构书面同意，本报告、评级观点和评级结论不得用于其他债券的发行等证券业务活动。本评级机构 对本报 ...

6月5日，A股三大指数走势震荡。科创芯片指数截至发稿涨0.54%。 甬兴证券表示，大厂持续对AI基础设施投资，推动算力产业链行业发展。马斯克近日表示，他预计特 斯拉和xAI将继续从半导体巨头Nvidia和AMD购买芯片，可能还有其他。我们认为，AI需求持续增加产 业链景气度向上，算力产业链将持续受益。受益于新品不断推出，看好AI端侧产业链；受益于新款芯 片不断研发，看好消费电子产业。 中信证券研报认为，近日，博通透露其新一代Tomahawk6交换芯片已启动交付，目前客户需求十分旺 盛。Tomahawk6性能提升显著，可以支持百万XPU的集群部署。网络速率升级与算力集群扩张依然是长 期发展趋势，Tomahawk6的量产有望推动1.6T光模块与数据中心互联(DCI)需求的快速增长。同时此次 Tomahawk6亦发布了共封装光学技术(CPO)版本，有望推动CPO方案的成熟。深入布局高速数通模块、 DCI互联与CPO方案的光模块/器件厂商有望受益。 相关ETF方面，科创芯片ETF（588200）早盘震荡走高，截至发稿涨0.54%，成交额超3.1亿元。成分股 中，睿创微纳涨超4%，南芯科技、翱捷科技-U、复旦微电、思特 ...

Group 1 - The Shanghai Military Industry Index (H50036) opened lower but rose by 0.59% to 7310.45 points, with a trading volume of 17.688 billion yuan [1] - Over the past month, the Shanghai Military Industry Index has increased by 5.42%, by 5.28% over the last three months, and by 0.72% year-to-date [1] - The index includes listed companies primarily engaged in the military industry, selected from the ten major military groups and other related firms, reflecting the overall performance of military industry stocks in the Shanghai market [1] Group 2 - The top ten weighted stocks in the Shanghai Military Industry Index are: China Shipbuilding (9.82%), AVIC Shenyang Aircraft (7.76%), China Heavy Industry (7.25%), Aero Engine Corporation (6.74%), AVIC Aircraft (4.01%), China Power (3.5%), Aerospace Electronics (3.44%), Western Superconducting (3.2%), Ruichuang Micro-Nano (3.13%), and Lianchuang Optoelectronics (3.1%) [1] - The index is fully composed of stocks listed on the Shanghai Stock Exchange, with an industry composition of 77.10% in industrials, 12.67% in information technology, 6.07% in materials, 3.13% in communication services, and 1.03% in consumer discretionary [1] Group 3 - The index samples are adjusted biannually, with changes implemented on the next trading day following the second Friday of June and December, with sample adjustments generally not exceeding 10% [2] - Weight factors are adjusted in accordance with sample changes, remaining fixed until the next scheduled adjustment, with provisions for temporary adjustments in special circumstances [2]

| 证券代码：688002 | 证券简称：睿创微纳 | 公告编号：2025-040 | | --- | --- | --- | | 转债代码：118030 | 转债简称：睿创转债 | | 烟台睿创微纳技术股份有限公司 关于本次限制性股票归属登记完成后 调整可转债转股价格暨转股停牌的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券停复牌情况：适用 因烟台睿创微纳技术股份有限公司（以下简称"公司"）本次限制性股票归属完成 登记增发新股，引发"睿创转债"转股价格调整,本公司的相关证券停复牌情况如 下： | | | 一、可转换公司债券转股价格调整依据 公司已于 2025 年 5 月 29 日完成了 2020 年限制性股票激励计划首次授予部分 第四个及预留授予部分第三个归属期的归属登记手续，公司总股本 454,922,802 股增加至 455,971,925 股，具体内容详见公司于同日在上海证券交易所网站 （www.sse.com.cn）披露的《关于 2020 年限制性股票激励计划首次授予部分第四 调整前转股价 ...

证券代码：688002 证券简称：睿创微纳 公告编号：2025-039 烟台睿创微纳技术股份有限公司 关于 2020 年限制性股票激励计划首次授予部分 第四个及预留授予部分第三个归属期归属结果 暨股份上市的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 本次股票上市类型为股权激励股份；股票认购方式为网下，上 市股数为1,049,123股。 本次股票上市流通总数为1,049,123股。 本次股票上市流通日期为2025 年 6 月 5 日。 根据中国证监会、上海证券交易所、中国证券登记结算有限责任公司上海分 公司有关业务规则的规定，烟台睿创微纳技术股份有限公司（以下简称"公司"）于 2025 年 5 月 29 日收到中国证券登记结算有限责任公司上海分公司出具的《证券变 更登记证明》，公司于 2025 年 5 月 29 日完成了公司 2020 年限制性股票激励计划 （以下简称"本激励计划"）首次授予部分第四个及预留授予部分第三个归属期的 股份登记工作。现将有关情况公告如下： 重要内容提示： 一、本次限制性股票归属的决策程序 ...

Core Viewpoint - The Chinese innovative pharmaceutical industry is transitioning from imitation to original innovation, with significant growth in outbound transactions and a promising future for internationalization [4] Group 1: Market Performance - As of May 29, 2025, the Sci-Tech Innovation Board 100 Index (000698) rose by 1.63%, with notable increases in constituent stocks such as Borui Pharmaceutical (688166) up 9.66% and Zhixiang Jintai (688443) up 6.57% [3] - The Sci-Tech 100 Index ETF (588030) increased by 1.60%, with a latest price of 0.95 yuan and a turnover rate of 1.16%, totaling 71.56 million yuan in transactions [3] - Over the past year, the average daily transaction volume of the Sci-Tech 100 Index ETF reached 424 million yuan, ranking first among comparable funds [3] Group 2: Fund Growth and Performance - The Sci-Tech 100 Index ETF saw a significant increase in scale, growing by 94.45 million yuan over the past two weeks, ranking second among comparable funds [4] - In the past week, the ETF's shares increased by 99 million, also ranking first among comparable funds [5] - The ETF has experienced a net inflow of 71.08 million yuan over the last five trading days, indicating strong investor interest [5] Group 3: Financial Metrics - As of May 28, 2025, the Sci-Tech 100 Index ETF's net value increased by 19.94% over the past year, with a maximum monthly return of 27.67% since inception [5] - The ETF's management fee is 0.15% and the custody fee is 0.05%, making it the lowest among comparable funds [5] - The tracking error for the ETF over the past six months is 0.016%, indicating high tracking precision compared to similar funds [5] Group 4: Industry Insights - From the beginning of 2025 to the present, the total outbound transaction amount for innovative drugs has reached 45.5 billion USD, with upfront payments totaling 2.2 billion USD, suggesting a record year ahead [4] - Most domestic innovative drugs currently in the U.S. are in clinical stages, with significant potential for future growth as they progress towards commercialization [4]

Group 1 - The company has conducted a self-examination regarding the trading of its stock by insiders related to the 2025 Restricted Stock Incentive Plan, confirming no insider trading occurred during the review period [2][3] - The self-examination period was defined as six months prior to the public disclosure of the incentive plan, from October 24, 2024, to April 24, 2025 [2] - Only one insider was found to have traded the company's stock during the self-examination period, and this trading was based on publicly available information without knowledge of the incentive plan [3] Group 2 - The company adhered to strict confidentiality measures and regulatory requirements throughout the planning of the incentive program, ensuring that only a limited number of personnel had access to insider information [3] - The company has confirmed that no insider information was leaked, and no insider trading based on the incentive plan's information was detected [3]

证券代码：688002 证券简称：睿创微纳 公告编号：2025-038 烟台睿创微纳技术股份有限公司 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 05 月 20 日 （二） 股东大会召开的地点：公司 A1 楼一楼会议室（中国（山东）自由贸易试 验区烟台片区烟台开发区南昌大街 6 号） （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： 普通股股东人数 157 普通股股东所持有表决权数量 170,062,743 例（%） 普通股股东所持有表决权数量占公司表决权数量的比例（%） 38.0743 （四） 表决方式是否符合《公司法》及公司章程的规定，大会主持情况等。 本次股东大会采用现场投票和网络投票相结合的方式召开，会议由董事长马宏先 生主持，本次会议的召集、召开程序符合《公司法》、 《证券法》、 《公司章程》的 规定。 （五） 公司董事、监事和董事会秘书的出席情况 ...